Maizel Ari bought AXSM
February 21, 2025 · Form 4 insider transaction
Maizel Ari bought 7,816 shares of Axsome Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,816
Price
$0.00
Total value
N/A
InsiderMaizel Ari
RoleOfficer
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 21, 2025
Filing dateFebruary 25, 2025
Shares owned after7,816
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on February 21, 2029.